U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07793643) titled 'AI-Powered Hepatitis C Single-Encounter Test-and-Treat' on Aug. 22.
Brief Summary: This study will evaluate a single-visit approach to hepatitis C treatment in patients seen in the emergency department. Participants with hepatitis C will receive rapid testing and, if eligible, hepatitis C medication before leaving the emergency department. The study will also use a smart pillbox, an AI-powered virtual agent, and community health worker support to help participants take their medication as prescribed. Participants will have follow-up visits and testing to assess medication adherence and whether the hepatitis C infection is cured.
St...